Erratum: Differences in mechanisms and outcomes of syncope in patients with coronary disease of idiopathic left ventricular dysfunction as assessed by electrophysiologic testing (Journal of the American College of Cardiology (2004) 44 (594-601) PII: S0735-1097(04)00950-7 and DOI: 10.1016/j.jacc.2004.03.075);Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing

Journal of the American College of Cardiology

Volumn 44, Issue 3, 2004, Pages 594-601

  Brembilla Perrot, Béatrice ^a   Suty Selton, Christine ^a   Beurrier, Daniel ^a   Houriez, Pierre ^a   Nippert, Marc ^a   Terrier De La Chaise, Arnaud ^a   Louis, Pierre ^a   Claudon, Olivier ^a   Andronache, Marius ^a   Abdelaah, Ahmed ^a   Sadoul, Nicolas ^a   Juillière, Yves ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

atrioventricular; AV; blood pressure; BP; DCM; dilated cardiomyopathy; electrophysiologic study; EPS; heart failure; HF; ICD; implantable cardioverter defibrillator; left ventricular; left ventricular ejection fraction; LV; LVEF; MI; myocardial infarction; SVTA

Indexed keywords

ADULT; AGED; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; FEMALE; HEART ELECTROPHYSIOLOGY; HEART FUNCTION TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART STIMULATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FLUTTER; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROPATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SYNCOPE; TREATMENT INDICATION;

EID: 4043050217     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.09.04     Document Type: Erratum

References (30)

1. Middlekauff H.R., Stevenson W.G., Warner Stevenson L., Saxon L.A. Syncope in advanced heart failure High risk of sudden death regardless of origin of syncope. J Am Coll Cardiol. 21:1993;110-116
2. Middlelkauf H.R., Stevenson W.G., Saxon L.A. Prognosis after syncope Impact of left ventricular function. Am Heart J. 125:1993;121-127
3. Exner D.V., Sheldon R.S., Pinski S.L., Kron J., Hallstrom A. AVID Investigators. Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy? Evaluation of the Canadian Implantable Defibrillator Study implantable cardioverter defibrillatory efficacy score in the Antiarrhythmics Versus Implantable Defibrillator Trial. Am Heart J. 141:2001;99-104
4. Multicenter Unsustained Tachycardia Trial Investigators, Lee K.L., Hafley G., Fisher J.D., et al. Effect of implantable defibrillators on arrhythmic events and mortality in the Multicenter Unsustained Tachycardia Trial. Circulation. 106:2002;33-38
5. Multicenter Automatic Defibrillator Implantation Trial II Investigators, Moss A.J., Zareba W., Hall J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 346:2002;877-883
6. Kapoor W.N. Current evaluation and management of syncope. Circulation. 106:2002;1606-1609
7. Mittal S., Iwai S., Stein K.M., Markowitz S.M., Slotwinner D.J., Lexman B.B. Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol. 34:1999;1082-1089
8. Josephson M.E. Should ICDs be implanted in patients with dilated cardiomyopathy and unexplained syncope? J Am Coll Cardiol. 33:1999;1971-1973
9. Morady F., Shen E., Schwartz A., et al. Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing. J Am Coll Cardiol. 2:1983;1053-1059
10. Olshanky B., Mazuz M., Martins J.B. Significance of inducible tachycardia in patients with syncope of unknown origin A long-term follow-up. J Am Coll Cardiol. 5:1985;216-223
11. Brembilla-Perrot B., Terrier de la Chaise A., Briançon S., et al. Programmed ventricular stimulation in survivors of acute myocardial infarction Long-term follow-up. Int J Cardiol. 69:1995;55-65
12. Brembilla-Perrot B., Beurrier D., Terrier de la Chaise A., et al. Significance and prevalence of atrial tachyarrhythmias in patients undergoing electrophysiologic study for presyncope or syncope. Int J Cardiol. 53:1996;61-69
13. Brembilla-Perrot B., Donetti J., Terrier de la Chaise A., Sadoul N., Aliot E., Juillière Y. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J. 121:1991;1124-1131
14. Olshansky B., Hahn E., Prater S., Mason J.W. ESVEM Investigators. Clinical significance of syncope in the Electrocardiographic Study Versus Electrocardiographic Monitoring (ESVEM) trial. Am Heart J. 137:1999;878-886
15. Andrews N.P., Fogel R.J., Pelargonio G., Evans J.J., Prystowsky E.N. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol. 34:1999;2023-2030
16. Mont L., Valentino M., Sambola A., Matas M., Aguinaga L., Brugada J. Arrhythmia recurrence in patients with a healed myocardial infarction who received an implantable defibrillator Analysis according to the clinical presentation. J Am Coll Cardiol. 34:1999;351-357
17. MUSTT Investigators, Buxton A.E., Lee K.L., Hafley G.E., et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease An analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation. 106:2002;2466-2472
18. Bourke J.P., Richards D.A.B., Ross D.L., McGuire M.A., Uther J.B. Does the induction of ventricular flutter or fibrillation at electrophysiologic testing after myocardial infarction have any prognostic significance? Am J Cardiol. 75:1995;431-435
19. Mittal S., Hao S., Stein K.M., Markowitz S.M., Slotwiner D.J., Lerman B.B. Significance of ventricular fibrillation in patients with coronary artery disease and unexplained syncope. J Am Coll Cardiol. 38:2001;371-376
20. International Study on Syncope of Uncertain Etiology (ISSUE) Investigators, Menozzi C., Brignole M., Garcia-Civera R., et al. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation. 105:2002;2741-2745
21. O'Donnell D., Hamer A., Horrigan M. Delayed neurally mediated syncope after inferior wall acute myocardial infarction. Am J Cardiol. 90:1999;157-159
22. Alboni P., Brignole M., Menozzi C., et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol. 37:2001;1921-1928
23. Sheldon R., Rose S., Koshman M.L. Isoproterenol tilt-table testing in patients with syncope and structural heart disease. Am J Cardiol. 78:1996;700-703
24. Link M.S., Kim K.M.S., Homoud M.K., Estes M. III, Wang P.J. Long-term outcome of patients with syncope associated with coronary artery disease and a nondiagnostic electrophysiologic evaluation. Am J Cardiol. 83:1999;134-137
25. Letorier P., Krahn A.D., Lein G.J., Yee R., Skanes A.C. Comparison of patients with syncope with left ventricular dysfunction and negative electrophysiologic testing to cardiac arrest survivors and patients with syncope and preserved left ventricular function and impact of an implantable defibrillator. J Am Coll Cardiol. 78:2002;77-79
26. Tischler M.D., Lee T.H., McAndrew K.A., Sax P.E., St. John Sutton M., Lee R.T. Clinical, echocardiographic and Doppler correlates of clinical instability with onset of atrial fibrillation. Am J Cardiol. 66:1990;721-724
27. Brilakis E., Shen W.K., Hammill S.C., Hodge D.O., Lexvold N.Y., Friedman P.A. Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope. Pacing Clin Electrophysiol. 24:2001;1623-1630
28. Knight B., Goyal R., Pelosi F., et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol. 33:1999;1964-1970
29. Grimm W., Hoffmann J., Menz V., Luck K., Maisch B. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol. 32:1998;739-745
30. Grimm W., Hoffmann J., Müller H.H., Maish B. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol. 39:2002;780-787